The ethics of phase I trials of biologic agents

被引：2
|
作者：
Hanauer, Stephen B.
机构：
[1] SB Hanauer is Editor-in-Chief of Nature Clinical Practice Gastroenterology & Hepatology.,
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2008年 / 5卷 / 10期
关键词：
D O I：
10.1038/ncpgasthep1259
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [41] A review of clinical trials of biologic agents and small molecules for psoriasis in Asian subjects
    Tsai, Ya-Chu
    Tsai, Tsen-Fang
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2016, 151 (04): : 412 - 431
  • [42] I am a clone. The ethics in the trials of biotechnology
    Goffi, Jean-Yves
    PHILOSOPHIQUES, 2005, 32 (02): : 459 - 462
  • [43] Relation of pharmacodynamic monitoring to response and MTD in phase I/II trials of antiangiogenic agents.
    Harris, AL
    CLINICAL CANCER RESEARCH, 2000, 6 : 4472S - 4472S
  • [44] Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials
    Codesido, Montserrat Blanco
    Brunetto, Andre Tesainer
    Frentzas, Sophia
    Garcia, Victor Moreno
    Papadatos-Pastos, Dionysis
    Pedersen, Joanna Vitfell
    Trani, Leonardo
    Puglisi, Martina
    Molife, L. Rhoda
    Banerji, Udai
    ONCOLOGY, 2011, 81 (02) : 135 - 140
  • [45] Learning from toxicity patterns in phase I trials during the era of mechanism targeted agents
    Greystoke, A.
    Ranson, M.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 1934 - 1936
  • [46] Clinical benefit in phase I trials of novel molecularly targeted agents: Does dose matter?
    Postel-Vinay, S. C.
    Arkenau, H.
    Ashley, S.
    Barriuso, J.
    Olmos, D.
    Shaw, H.
    Wright, M.
    Judson, I.
    De-Bono, J.
    Kaye, S. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer
    Arkenau, Hendrik-Tobias
    Brunetto, Andre T.
    Barriuso, Jorge
    Olmos, David
    Eaton, David
    de Bono, Johann
    Judson, Ian
    Kaye, Stan
    ONCOLOGY, 2009, 76 (03) : 151 - 156
  • [48] Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations
    K Itoh
    Y Sasaki
    H Fujii
    T Ohtsu
    H Wakita
    T Igarashi
    K Abe
    British Journal of Cancer, 1997, 76 : 107 - 113
  • [49] Logistic retainment interval dose exploration design for Phase I clinical trials of cytotoxic agents
    Murray, Thomas A.
    PHARMACEUTICAL STATISTICS, 2021, 20 (04) : 850 - 863
  • [50] PHASE-I TRIALS OF SINGLE AGENTS IN ADULT SOLID TUMORS - PRECLINICAL AND CLINICAL ASPECTS
    DODION, P
    KENIS, Y
    STAQUET, M
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1986, 12 (1-3) : 23 - 30
12345